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Objectives. To identify independent risk factors for visceral artery aneurysms.
Methods. Retrospective medical record review over 10 years.
Results. There were 26 men and 15 women, median age of 54 (range 22 to 85), and median follow-up was 20.6 months
(range 0 to 94 months). There were 11 splenic, 17 hepatic, 8 gastroduodenal, 6 pancreatoduodenal, 5 superior mesenteric,
and two inferior mesenteric artery aneurysms. Thirteen patients (13/41, 31.7%) were treated surgically without adjuvant
endovascular intervention. Nineteen patients (19/41, 46.3%) were treated exclusively using endovascular procedures. Five
patients (5/41, 12.2%) received second endovascular or surgical treatment as salvage procedure after the first procedure
failed.
Concomitant malignancy was positive predictors for in-hospital death. Renal failure, chronic lung disease, liver cirrho-
sis, previous abdominal surgery and concomitant malignancy were positive predictors of 2-year mortality. With the inten-
tion to treat in the whole cohort, less than 10% (2/21) of the endovascular treatments failed, compared to 18.5% (3/16) in
the surgical group. Patients treated by surgery without aid of endovascular intervention, have lower 2-year mortality. In
hospital-death rate was 9.8%, while overall mortality rate was 21.9%.
Conclusions. The endovascular intervention provides compatible, even better early postoperative outcomes for visceral
artery aneurysms to surgery. Concomitant malignancy was the major determinant of visceral artery aneurysms, both
in-hospital death and survival.
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Visceral artery aneurysms are rare,with an incidence of
just 0.01% to 0.2% in routine autopsies. The pathogene-
sis and natural course of this disease remain poorly un-
derstood, literature reviews on this subject is scarce.1
Visceral artery aneurysms are clinically important
and potentially lethal. In 1986, Stanley et al reported
that 22%of all visceral artery aneurysmspresent as clin-
ical emergencies, while 8.5% result in death.2
In contrast to splenic artery aneurysms, which are
historically the most common form of visceral artery
aneurysms, hepatic artery aneurysms were the most
frequently reported visceral artery aneurysm between
1985e1995.3,4 This increased incidence of hepatic
artery aneurysms is related to growing use of percuta-
neous biliary procedures, liver transplantations and
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blunt liver injury.5,6
Despite recent advances in therapeutic techniques
and diagnostic tools, the management of visceral ar-
tery aneurysms remains clinically challenging. This
study reviewed the outcomes of 41 patients with vis-
ceral artery aneurysms and identified independent
clinical variables associated with poor prognosis.
Patients and Methods
Patients
Information was collected retrospectively on all pa-
tients diagnosed with visceral artery aneurysms that
occurred between June 1995 and June 2005. Data on
age, sex, medical co-morbidity, aneurysm location, in-
tervention, surgical procedure and clinical outcome
were recorded according to standard guideline. The
sample comprised 41 patients diagnosed with 49 vis-
ceral artery aneurysms.rved.
294 Y.-K. Huang et al.Definite infective endocarditis diagnosis was made
according to Duke modification of the von Reyn
criteria.7
In-hospital mortality defined as death within 30
days following intervention or following visceral
artery aneurysms were diagnosed. Aneurysm-related
death included recurrent gastrointestinal bleeding,
free rupture into peritoneal, local abscess around the
aneurysm and other conditions that directly attrib-
uted to the visceral artery aneurysms. Hospital stay
dated from definite diagnosis of the visceral artery an-
eurysms to discharge or to death.
Typically, surgery and endovascular interventions
are generally considered for patients with aneurysm
>2 cm in diameter, rapid growth in aneurysm size,
and symptoms attributable to the aneurysms. The de-
cision to perform surgical or endovascular interven-
tion was based on anatomic suitability and patient
comorbidities. Observation is only reserved for
asymptomatic patients with visceral artery aneurysms
<2 cm in diameter.
Surgical technique
Surgical management comprised wide excision of an-
eurysms, with or without en bloc resection of adjacent
organs.8 Vascular reconstructions were performed in
those with stable hemodynamic condition. In cases in-
volving hypovolemic shock and multiple co-morbid
patients, the surgical intervention included ligation of
the feeding artery and aneurysmectomy. Surgical man-
agement for endovascular access complications, such
as uncontrolled puncture site bleeding and femoral
artery pseudoaneurysm, was excluded from analysis.
Endovascular intervention
Endovascular intervention consisted of coil emboliza-
tion and absorptable gelatin sponge cube (Gelform)
embolization performed via a percutaneous trans-
femoral approach. Interventions were performed by
interventional radiologists under local anesthesia.
Endovascular stent grafts for visceral artery aneu-
rysms were not available in our institution within
the period of this study.
Statistical analysis
Continuous variables were compared using an un-
paired 2-tail Student t test. Moreover, discrete variables
were compared using a 2-tailed Fisher exact test. Clin-
ical parameters associated with survival were tested
through log-rank analysis. The relative importance ofEur J Vasc Endovasc Surg Vol 33, March 2007the clinical variables was further assessed with a Cox
proportional hazard model analysis. The actuarial sur-
vival curve was performed with the Kaplan-Meier
method. All statistical analysis was conducted using
STATA statistics/Data Analysis 8.0 software (Stata
Corporation, College Station, TX). The results are
mostly presented as mean values SD. Statistical
significance was defined as p value 0.05.
Results
Patients
Table 1 lists the detailed distribution of aneurysms,
gender ratio, and visceral-artery aneurysms-related
procedures. The sample included 26 men and 15
women with a median age of 54 (range, 22e85 years)
on admission, and the median age of 54 (range 22 to
85), and median follow-up was 20.6 months (range
0 to 94 months). Seven patients had multiple aneu-
rysms. There were 11 splenic, 17 hepatic, eight
gastroduodenal, six pancreatoduodenal, five superior
mesenteric, and two inferior mesenteric artery
aneurysms.
Medical co-morbid condition included diabetes
mellitus in four patients, chronic obstructive lung dis-
ease in four patients, history of stroke in six patients,
infective endocarditis in five patients, liver cirrhosis in
nine patients, hypertension in fifteen patients, chronic
renal failure with hemodialysis in two patients and
systemic lupus erythematosus in two patients. Twenty
patients had previous abdominal surgery. Eleven
patients had malignancy (five pancreatic cancer, one
Klatskin tumor, one hepatic cell carcinoma, one gas-
tric cancer, one cervical cancer, one cholangiocarci-
noma and one leukemia).
Four in-hospital deaths occurred, three of them re-
lated to the visceral artery aneurysms. The first case
had received pancreaticoduodenectomy (Whipple’s
operation) for pancreatic cancer one month previously,
with presentation of jaundice, severe upper gastro-
intestinal bleeding, and hypovolemic shock. Emergent
arterial angiography disclosed a common hepatic an-
eurysm, which ruptured into the gastrointestinal tract.
Although hemostasis was temporarily achieved by
transcatheter coil embolization, the patient eventually
succumbed as a result of recurrent bleeding. The sec-
ond patient was a recurrence of hepatocellular carci-
noma after hepatectomy, with lung metastasis. The
patient presented with gastrointestinal bleeding, and
angiography revealed a proximal gastroduedenal arte-
rial aneurysm. The transcatheter emoblization failed to
achieve complete hemostasis, and the exploratory
295Visceral Artery Aneurysm Risk Factor AnalysisTable 1. Demographics, etiology and aneurysm-related procedure
Demographics Etiology Intervention
Aneurysm location Patient no % M/F A I E P Surg Cath Both Obs
Splenic artery 9 22.0 5/4 8 0 0 1 6 0 0 3
Splenic artery, Proximal 3 3 2 1
Splenic artery, Distal 3 3 3
Splenic artery, undefined 1 1 1
Multiple aneurysm 2* 2 1 1
Hepatic artery 14 34.1 9/5 2 10 1 1 2 10 1 1
Left hepatic artery 2 2 2
Right hepatic artery 4 3 1 3 1
Common hepatic artery, single 5 4 1 2 3
Celiac artery 1 1 1
Bilateral hepatic artery 1** 1 1
Common hepatic artery, multiple 1* 1 1
GDA and PDA 11 26.8 9/2 2 5 1 3 2 8 1 0
GDA 6 2 3 1 1 4 1
GDA, multiple 1* 1 1
PDA 2 1 1 1 1
PDA, multiple 2* 1 1 2
SMA and IMA 7 17.1 3/4 1 3 3 0 3 1 3 0
Ileal artery, proximal 2 1 1 1 1
mesentary artery, distal 3 1 2 2 1
IMA trunk 1 1 1
left colic artery 1 1 1
sum 41 26/15 13 19 5 4
Abbreviation. IMA: inferior mesenteric artery; GDA: gastroduodenal artery; PDA: pancreaticoduodenal artery; SMA: superior mesenteric
artery.
Etiology A: atherosclerotic; Etiology I: iatrogenic (recent abdominal surgery); Etiology E: infective endocarditis; Etiology P: pancreatitis and
intraabdominal abscess.
Surg: surgical-alone group; Cath: trans-catheter based therapy; Both: received surgery and transcatheter treatment; Obs: observation.
* two aneurysms.
** three aneurysms.laparotomy was performed as a salvage procedure.
The patient survived this episode but died of recurrent
bleeding and sepsis three months later. The third pa-
tient had leukaemia with gastrointestinal bleeding
during chemotherapy. This patient received multiple
abdominal operations, including hepatojejunostomy
for choledochocyst three years previously and T-tube
insertion 20 days before the gastrointestinal bleeding.
Angiographic study demonstrated a pseudoaneurysm
from the posterior branch of the right hepatic artery
that ruptured into the biliary tract, and the aneurysm
was subsequently by coil embolization. The patient
died of sepsis two weeks later. The fourth patient
was a case splenic artery aneurysm. She was bed-
ridden and had multiple co-morbidities, which pre-
cluded further intervention after the diagnosis. The
patient died of intra-abdominal abscess.
Five patients died during follow-up. One patient
received transcatheteric coil embolization for multiple
pancreatico-duodenal artery aneurysms. This patient
was admitted again two months later for pancreatic
abscess around the aneurysm, and finally died ofsepsis. The in-hospital death rate was 9.8% for this
study, while two mortality rate was 21.9%.
Clinical presentations
The clinical presentations of the visceral artery aneu-
rysms are listed in Table 2. Five patients (5/41, 12%)
were asymptomatic; four splenic artery and one com-
mon hepatic artery aneurysm. Eighty-eight percent of
Table 2. Symptoms of visceral artery aneurysm
Presenting symptoms No of patients %
Asymptomatic 5 12
Symptomatic 36 88
Gastrointestinal bleeding 21 51.2
Abdominal pain 17 41.4
Shock 11 26.8
Rupture into peritoneum 5 12.2
Fever 5 12.2
Hemobilia 3 7.3
Jaundice 2 4.9Eur J Vasc Endovasc Surg Vol 33, March 2007
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trointestinal bleeding and abdominal pain were the
most common symptoms, occurring in 50 and 43 per-
cent of patients respectively. Eleven patients pre-
sented with hypovolemic shock: five cases were
rupture of the aneurysm into the peritoneum and
six patients with rupture into gastrointestinal tract
causing massive bleeding.
Among five patients with infective endocarditis as
initial clinical presentation, blood cultures were posi-
tive for Streptococcus species in three patients. The re-
sponsible organisms in the remaining two patients
were Escherichia coli and S. aureus.
Surgery-alone
Thirteen patients (13/41, 31.7%) were treated surgi-
cally without adjuvant endovascular intervention.
The surgical procedures, aneurysm locations and as-
sociated condition, are summarized in Table 3. The
surgical procedures for the splenic artery aneurysms
included aneurysmectomy with splenectomy (5/9)
and aneurysmectomy with autologous graft inter-
position (1/9). Among the patients who received
splenectomy, two distal pancreatectomy and one gas-
trorraphy were performed concomitantly. Meanwhile,
among the aneurysms involving the hepatic, gastro-
duodenal, and pancreaticoduodenal arteries, surgical
intervention was the only procedure in four patients.
Three superior mesenteric artery aneurysms were
treated surgically. Two of these patients subsequently
Table 3. Surgical procedures in Surgery-alone group
Artery no Surgical procedures
Splenic
artery
2 Aneurysmectomy with splenectomy
2 splenectomy, distal pancreadectomy and
aneurysmectomy
1 Aneurysmectomy and venous graft interposition
(spleen preserve)
1 Aneurysmectomy with splenectomy, gastrorraphy
(aneurysm rupture into stomach)
Hepatic
artery
1 Aneurysmectomy and venous graft interposition
1 Ligation of gastroduodenal and common hepatic
artery
GDA and
PDA
1 near total pancreadectomy and aneurysmectomy
1 Suture-ligation of the aneurysm in which
ruptured into pancreatic pseudocyst
SMA 1 Aneurysmectomyþ omentum flap (Mitral valve
repair later)
1 Aneurysmectomy, no bowel resection (Aortic
valve endocarditis)
1 Aneurysmectomy, no bowel resection (Mitral
valve vegitation)
GDA: gastroduodenal artery; PDA: pancreatoduodenal artery;
SMA: superior mesentary artery.Eur J Vasc Endovasc Surg Vol 33, March 2007underwent cardiac valve surgery (mitral valve repair
and mitral valve replacement).
Endovascular-alone
Nineteen patients (19/41, 46.3%) were treated exclu-
sively using endovascular procedures, including
trans-arterial coil embolization and gelatin sponge
cube (Gelform) embolization for the feeding arteries.
Other therapeutic conditions
Five patients (5/41, 12.2%) received both endovascular
and surgical treatment for visceral artery aneurysms.
The indications, procedure detail and aneurysm
locations are listed in Table 4. Two patients received
surgical salvage following endovascular procedures,
one for the incomplete endovascular hemostasis and
the other for post-embolization ischemic colon. And
three patients underwent endovascular intervention
for incomplete surgical hemostasis. With the intention
to treat in the whole cohort, less than 10% (2/21) of
the endovascular treatments failed, compared to
almost 18.5% (3/16) in the surgical group. Four
patients (4/41, 9.8%) were treated conservatively.
Outcome according to therapeutic approaches
Clinical features and outcomes were compared be-
tween the surgery-alone group and the endovascular-
alone group (Table 5). The two groups did not
differ in terms of gender, medical conditions, serum
albumin level, total bilirubin level, in-hospital death,
and aneurysm-related death.
Patients in the surgery-alone group were less previ-
ous abdominal surgery ( p< 0.001) and frequently
presenting with abdominal pain ( p¼ 0.029). There
was a lower incidence of presentation with gastro-
intestinal bleeding ( p¼ 0.01) and lower two-year mor-
tality ( p¼ 0.025) in surgery alone group. In general,
patients with visceral artery aneurysms, who toler-
ated surgery without the aid of endovascular inter-
vention, had better health condition and longer
survival.
Risk factor analysis
In-hospital death occurred in four patients, and was
related to visceral artery aneurysms in three cases.
Aneurysm-related death occurred in four patients,
of whom three died in hospital and one died of
intra-abdominal abscess around the visceral artery
297Visceral Artery Aneurysm Risk Factor AnalysisTable 4. Combined procedure in detail
Sequence aneurysm surgery cath Why
1 cath then
surgery
Proximal GDA exploratory ligation, of CHA and GDA coil embolization, coil 5 incomplete embolization
2 cath then
surgery
left colic artery Hemicolectomy coil embolization, coil 3 Ischemic colon
3 surgery
then cath
proximal ileal
artery
exploratory laparotomy, severe bowel
adhesion due to previous gastrectomy
coil embolization, coil 2 3 mm
and 2 5 mm microcoil
incomplete surgical
hemostasis
4 surgery
then cath
inferior mesentary
artery
exploratory laparotomy for peritoneal
sign, severe bowel adhesion due to
previous pelvic surgery
coil embolization, coil 2 cath as salvage procedure
for surgery
5 surgery
then cath
right hepatic
artery
exploratory laparotomy for peritoneal
sign, severe bowel adhesion due to
previous gastrectomy
coil embolization, two of 2 3
microcoil
cath as salvage procedure
for surgery
CHA: common hepatic artery; GDA: gastro-duodenal artery.aneurysm two months after discharge. Eleven pa-
tients required hospital stay exceeding 30 days to
complete their therapeutic course. There were nine
patients dead at 2 years follow-up. The 30-day, 90-
day, 1-year and 2-year estimated mortality rates
were 9.8%, 9.8%, 14.6% and 21.9%, respectively.
For all 41 patients, concomitant malignancy was
positive predictors of in-hospital death ( p¼ 0.003).
Meanwhile, renal failure ( p< 0.01), chronic lung
disease ( p< 0.01), liver cirrhosis ( p¼ 0.018), previous
abdominal surgery ( p¼ 0.017) and concomitant ma-
lignancy ( p< 0.01) were positive predictors of 2-year
Table 5. Comparison of surgery-alone vs endovascular-alone
groups
Variable Surgery alone
(n¼ 13)
Endovascular
alone (n¼ 19)
P
n % n %
Male gender 8 61.50 13 68.42 .699a
Age (year) 45.6 19.1 56.4 13.2 .069
Albumin (g/dl) 3.23 0.80 2.83 0.733 .156
Hemoglobin (g/dl) 11.26 2.15 8.40 1.59 <.001*
total bilirubin (mg/dl) 1.32 1.16 3.71 4.34 .064
Chronic lung disease 1 7.69 2 10.53 .999a
Diabetes mellitus 0 0.00 3 15.79 .253a
Systemic lupus
erythematosus
1 7.69 1 5.26 .999a
Endocarditis 3 23.10 2 10.53 .374a
History of stroke 1 7.69 3 15.79 .629a
Hemodialysis 0 0.00 2 10.53 .502a
Hypertension 4 30.84 7 36.84 .999a
Liver cirrhosis 1 7.69 7 36.84 .101a
Maligancy 1 7.69 8 42.11 .050a
Previous abdominal
surgery
0 0.00 16 84.21 <.001a*
Abdominal pain 9 69.23 5 26.32 .029a*
Upper gastrointestinal
bleeding
3 23.08 14 73.68 .010a*
In-hospital death 0 0.00 2 10.53 .502a
Admission >30 days 5 38.46 4 21.05 .427a
Aneurysm-related death 0 0.00 2 10.53 .502a
Two-year Mortality 0 0.00 7 32.14 .025a*
*: P< .05.
a Fisher Exact Test.mortality. Surgical treatment of visceral artery aneu-
rysms without aid of endovascular intervention was
a negative predictor of 2-year mortality ( p¼ 0.023)
(Table 6).
Cox proportional Hazard model to test the poten-
tial risk factor for survival are showed in Table 7. Con-
comitant malignancy has the most significant impact
(Hazard ration: 39.17, P¼ 0.008) on the survival, fol-
lowed by chronic lung disease (Hazard ratio: 18.3,
P¼ 0.026).
Discussion
With the increasing adoption of computed tomogra-
phy and angiography, many visceral artery aneu-
rysms are being identified before complications,
specifically in patients being evaluated for abdominal
pain or gastrointestinal bleeding. Management of vis-
ceral artery aneurysms remains an extremely chal-
lenging clinical problem. Significant questions exist
regarding to the optimal therapeutic choice (surgery
vs endovascular procedure), and the predictors of
clinical outcome.
Therapeutic Choice in Different Condition
Surgery is the conventional treatment of visceral ar-
tery aneurysms, and its efficiency and durability
were well documented.5,10e13 Angiographic emboliza-
tion of visceral artery aneurysms was an emerging op-
tion and the results obtained via this technique have
been constantly improving. However, there are few
studies examining the long-term results of endovascu-
lar treatment. This study will demonstrates the influ-
ence on the therapeutic choice of aneurysms locations,
presenting symptoms and history of abdominal
surgery.Eur J Vasc Endovasc Surg Vol 33, March 2007
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Variable n¼ 41 p Valuesa p Valuesa p Valuesb
n (%) In-hospital
Death (n¼ 4)
Aneurysm-related
Death (n¼ 4)
Mortality at
2 years (n¼ 9)
Male 26 (63) 0.999 0.999 0.6825
Risk Factors
Diabetes Mellitus 4 (10) 0.348 0.348 0.0853
Hypertension 15 (37) 1 0.615 0.1496
Cerebrovascular Disease 6 (15) 0.483 0.095 0.0895
Coronary Artery Disease 2 (5) 1 0.188 0.3929
Congestive Heart Failure 2 (5) 1 0.188 0.3929
Infective Endocarditis 5 (12) 1 0.418 0.9586
Smoker 7 (17) 0.542 0.542 0.1016
COPD 4 (10) 0.348 0.041c 0.0045c
Renal Failure with Dialysis 2 (5) 1 0.188 0.0009c
Autoimmune Disease 2 (5) 1 1 0.4328
Liver Cirrhosis 9 (22) 1 1 0.0182c
Concomitant Malignancy 11 (27) 0.003c 0.052 0.0028c
Past Abdominal Surgery 20 (49) 0.343 0.343 0.0165c
Type of Intervention
Combined Procedures 5 (12) 0.418 0.148 0.8183
Surgery-alone 13 (32) 0.288 0.288 0.0232c
Endovascular alone 19 (46) 1 1 0.0744
COPD¼Chronic obstructive pulmonary disease.
a By Fisher’s exact test.
b By log-rank test.
c p Value <0.05.Splenic artery aneurysms
Sixty-six percent of splenic artery aneurysms in the
present series (6/9) were excised surgically, and
none received endovascular coil embolization. For
splenic artery aneurysms, surgery generally consists
of splenectomy and the removal of the portion of
the splenic artery containing the aneurysm (aneurys-
mectomy). Distal pancreatectomy is performed when
the aneurysms are deeply embedded within the pan-
creatic tissue. Splenic preservation without vascular
reconstruction carries a risk of splenic infarction or
abscess formation.14 If the spleen is to be preserved
during aneurysmectomy, then vascular reconstruction
is required. This could be accomplished using an au-
tologous saphnenous vein. Laparoscopic ligation
has also been described for splenic artery aneurysms
with good results, but experience of this procedure is
limited.15e17 Endovascular treatment is an emergingEur J Vasc Endovasc Surg Vol 33, March 2007therapy for splenic artery aneurysms. Notably, endo-
vascular embolizations are prone to develop major
complications with distal splenic artery aneurysms,
and should be avoided in such cases.18
There is a general consensus that treatment of
asymptomatic splenic artery aneurysms is appropri-
ate in pregnant patients or in women likely to become
pregnant.19 Rupture of splenic artery aneurysms most
often occurred during pregnancy and was associated
with a high maternal and fetal mortality rate. The op-
posite three patients in this series (one man and two
menopausal women) with splenic artery aneurysms
were safely observed.
Hepatic, gastroduodenal and pancreatoduodenal artery
aneurysms
In contrast to the splenic artery aneurysms, the aneu-
rysms located in the hepatic, gastroduodenal andTable 7. Cox proportional Hazard model for potential risk factors affecting actural survival
Variance Hazard Ratio Standard Error z P> jzj 95% Confidence Interval
Diabetes mellitus 3.570796 6.442629 0.71 NS 0.1039872 122.6169
Hypertension 0.9682991 0.9034042 0.03 NS 0.1555446 6.027872
Chronic lung disease 18.38065 24.03521 2.23 0.026 1.416767 238.4642
Hemodialysis 12.82021 23.85307 1.37 NS 0.3343205 491.6172
Liver cirrhosis 5.885139 6.041003 1.73 0.084 0.7870671 44.00497
Previous abdominal surgery 1.251891 2.109807 0.13 NS 0.0460299 34.04809
Concominant Malignancy 39.17421 53.84024 2.67 0.008 2.64927 579.2611
NS: non significant, P> 0.05.
299Visceral Artery Aneurysm Risk Factor Analysispancreatoduodenal arteries are mainly treated with
endovascular intervention in this series. Only four
patients with hepatic, gastroduodenal and pancreato-
duodenal artery (4/25, 16%) were treated surgically
without adjuvant endovasucular procedures. The
main presenting signs of these visceral artery aneu-
rysms are primarily intractable gastrointestinal
bleeding, and definite diagnoses were obtained by
via angiography arranged following a negative pan-
endoscopic examination for peptic ulcer. Aneurysms
of the proximal hepatic artery were treated via exci-
sion or exclusion without vascular reconstruction.
Collateral circulation is usually sufficient through the
superior mesenteric artery to the gastroduodenal
artery. Revascularization should be performed in the
distal lesion of hepatic arteries and those lesions in-
volving the gastroduodenal artery. For intra-hepatic
aneurysms, surgical correction may require hepatic
resection of the area involved or ligation of the re-
sponding hepatic artery before it enters the liver
parenchyma. In cases of pancreatoduodenal and gas-
troduodenal artery aneurysms, simple ligation is often
difficult because of the existence of multiple communi-
cating vessels. Endovascular coil embolization during
angiographic study takes advantage in easily identify-
ing and obliterating all the feeding arteries to the
aneurysm in cases with such anatomic restrictions.9
Superior mesenteric, inferior mesenteric and celiac artery
aneurysms
Superior mesenteric artery aneurysms account for 12%
(5/41) of all visceral artery aneurysms in the present
series, and mostly present as abdominal pain. Treat-
ment of superior mesenteric artery aneurysms is
mainly surgical, involving resection of the aneurysm
and replacement with a graft in situations where the
supply of blood to the bowel is compromised.8 One su-
perior artery aneurysm requires further endovascular
embolization following a failed surgical exploration
to achieve hemostasis. This patient was complicated
by severe bowel adhesion owing to previous gastrec-
tomy, which precluded complete surgical hemostasis.
Adjuvant transcathertic coli embolization was under-
taken to obliterate the feeding artery to the aneurysm
and stop the bleeding. Notably, there was a very
high percentage of concurrent infective endocarditis
among patients with superior mesenteric artery aneu-
rysms. Three of the superior mesenteric artery aneu-
rysms (60%) have concurrent infective endocarditis,
and two received subsequent cardiac valve surgery
(mitral valve repair and mitral valve replacement, re-
spectively). Visceral artery aneurysms in the superiorartery aneurysms warrant further survey of possible
infective endocarditis.8,9,20
Inferior mesenteric artery aneurysms can be treated
endovascularly, but caution is necessary to avoid
compromising the colon perfusion. One patient with
inferior mesenteric artery aneurysm received endo-
vascular coil embolization for inferior artery aneu-
rysm developed ischemic colon two days following
the procedure.
Influence of previous abdominal surgery and presenting
symptoms
Previous abdominal surgery and presenting symp-
toms also impact therapeutic choice. Surgical inter-
vention is more difficult in cases involving bowel
adhesion and anatomic variation following previous
abdominal surgery. Endovascular intervention thus
became the preferred treatment option for aneurysms
disclosed in the angiography for indeterminate gas-
trointestinal bleeding, especially in case of previous
abdominal surgery.21
Chiesa reported the surgical experience in 31 vis-
ceral artery aneurysms and concluded that an aggres-
sive surgical approach is justified by low morbidity
and mortality rates associated with surgery.13 None-
theless, the cases in Chiesa’s series weremainly splenic
artery aneurysms in atherosclortic origin, rather than
iatrogenic origin (i.e. aneurysm following abdominal
surgery). Visceral artery aneurysms treated by surgery
exclusively in our experience, also displayed excellent
result. As shown in the Fig. 1, the survival curves of
surgery alone and non-surgery alone groups, differ
significantly.
Although endovascular intervention is inferior in
terms of overall mortality, it achieves comparable effi-
ciency to surgery in reducing aneurysm-related death
and palliation of aneurysm-related symptoms, partic-
ularly in cases where surgery has been considered of
high risk. Notably, 42% of subjects in the endovascular
alone group exhibited history of malignancy and 84%
of abdominal surgery. Currently, with the growing use
of computed tomography and angiography, numer-
ous aneurysms are being discovered in patients with
poor clinical status. Such patients, who previously
may have been excluded from surgery, received ag-
gressive treatment via a less invasive endovascular
procedures.
Predictors of Outcome
Most previous studies of visceral artery aneurysms
described only few patients. Owing to the smallEur J Vasc Endovasc Surg Vol 33, March 2007
300 Y.-K. Huang et al.number of subjects, it is impossible to demonstrate the
statistically significant risk factors for the clinical
outcome. In the present study, concomitant malig-
nancy was positive predictors of in-hospital death
( p¼ 0.003). Chronic obstructive pulmonary disease
was a positive predictor of aneurysm-related death
( p¼ 0.041). Renal failure ( p< 0.01), chronic lung
disease ( p< 0.01), liver cirrhosis ( p¼ 0.018), previous
abdominal surgery ( p¼ 0.017) and concomitant
malignancy ( p< 0.01) were all positive predictors of
2-year mortality. Surgical treatment of visceral artery
aneurysms without aid of endovascular intervention
was a negative predictor of 2-year mortality
( p¼ 0.023). Aneurysm locations and different thera-
peutic choices were not predictors of in-hospital and
aneurysm-related death.
Study Limitations
A retrospective characteristic of heterogeneity of the
cohort is the major limitation of this investigation.
With such limitations, we attempted to identify
variables associated with poor prognosis and the
Fig. 1. A: Survival curve by Kaplan-Meier method in
patients with visceral artery aneurysms. B: survival curves
according to different therapeutic method (surgery alone
vs. non-surgery alone).Eur J Vasc Endovasc Surg Vol 33, March 2007influence of the treatment. However, this is the first
study to analyze risk factors for death in patients
with visceral artery aneurysms. Concomitant malig-
nancy is the variable most strongly associated with
aneurysm-related death as well as mortality. Further
multi-institutional studies may provide further infor-
mation regarding optimal therapeutic protocols and
prognostic factors.
Conclusion
This study improves upon previous research by de-
tailing the role of different therapeutic options and
analyzed prognostic factors in visceral artery aneu-
rysm. Concomitant malignancy is the major determi-
nant of in-hospital mortality.
Successful treatment of visceral artery aneurysms
requires high clinical suspicion, early diagnosis and
timely intervention. Compared to surgery, the endo-
vascular intervention provides compatible early post-
operative outcomes for visceral artery aneurysms.
Patients with visceral artery aneurysms, who toler-
ated surgery without the aid of endovascular inter-
vention, had better health condition and longer
survival.
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